Horizon Kinetics Medical ETFMEDX
Type
ETF
Peer group
Global equity
Net assets
$18.2M
Expense ratio
0.85%
1-year return
+29.0%
3 years, a year
+9.4%
5 years, a year
—
12-month yield
1.15%
Holdings
33
What it aims to do.
Horizon Kinetics Medical ETF ( Medical ETF or the Fund) seeks to provide long-term growth of capital.
Top 10 holdings.
| Holding | % of fund |
|---|---|
| LLY Eli Lilly & Co | 15.59% |
| US Bank Mmda - Usbgfs 7 | 10.03% |
| ABBV AbbVie Inc | 8.43% |
| NVS Novartis AG | 7.40% |
| JNJ Johnson & Johnson | 5.93% |
| AstraZeneca PLC | 5.71% |
| BMY Bristol-Myers Squibb Co | 5.13% |
| IONS Ionis Pharmaceuticals Inc | 4.73% |
| AMGN Amgen Inc | 4.19% |
| ALNY Alnylam Pharmaceuticals Inc | 4.14% |
More on MEDX.
- MEDX overview
- MEDX holdings
- MEDX risk
- MEDX costs
- MEDX money in and out
- MEDX share classes
- Compare MEDX with other funds
Returns after fees, from the fund's SEC filings up to Aug 2026. Past returns are not a promise. Not financial advice.